Key Highlights

  • Oracle (NYSE:ORCL) priced USD 20 billion of securities on November 2, 2026: 86,206,897 common shares at USD 116.00 for net proceeds of about USD 9.9 billion, plus USD 10.0 billion of senior notes.
  • The notes carry coupons from 7.000% to 8.650%, with tranches reported for 2029, 2031, 2033, 2037 and 2046, and both offerings are expected to close on November 4, 2026.
  • The USD 116 Offer Price sits about 2.7% below the USD 119.20 close on November 2, simple arithmetic on two published figures, after the shares slid about 8.6% that day.
  • Oracle said the proceeds are for general corporate purposes, which can include Capital spending and Debt repayment, while it affirmed about USD 70 billion of full-year capital expenditure.

The Terms of the Raise

Oracle (NYSE:ORCL) divided the raise roughly evenly between Equity and debt. The sale of 86,206,897 shares at USD 116.00 is worth about USD 10.0 billion before costs, consistent with the roughly USD 9.9 billion of net proceeds. The five note tranches priced between 7.000% and 8.650%, with the top coupon on the longest maturity, due in 2046. Those coupons are steep for a large technology issuer, and they show how much investors are charging to fund AI data centre spending. The release does not mention a mandatory convertible or an underwriters' option. Oracle shares fell about 8.6% in the regular session on November 2, while reports of that day's decline ranged from 5% to 9%.

Why Dilution and Funding Costs Matter

New shares dilute existing holders, and the USD 116 price is about 17.9% below the 50-day average of USD 141.25, which shows the discount investors demanded. The stock is down roughly 38% for the year and was described as near an 18-month low in one report. Oracle reported fiscal first-quarter Revenue up 30% to USD 19.35 billion and a Backlog of USD 664 billion, so Demand is not the concern. The concern is paying for capacity before revenue arrives. Share moves after pricing were reported inconsistently, from a 0.2% overnight change to a gain of 5.9% on November 3, so no single figure should be treated as settled. The USD 70 billion spending plan dwarfs the USD 20 billion raised, which suggests more funding may follow.

Risks and What to Watch

Higher interest costs squeeze free cash flow, and concentration in a handful of large AI contracts adds risk if any one of them slips. Oracle (NYSE:ORCL) has also signalled bigger plans, with published coverage citing a target of up to USD 50 billion of debt and equity in 2026. Investors should watch the closing on November 4, the next quarterly update on capital spending and any change to Credit ratings. For context, the Nasdaq Composite fell 1.07% on November 2 and the S&P 500 fell 0.51%, a session in which AI-linked shares were broadly weak. Interest on USD 10.0 billion at coupons of 7.000% to 8.650% works out to an annual cost near USD 0.8 billion, simple arithmetic that assumes an average coupon of about 8%.

Where Things Stand

Oracle (NYSE:ORCL) is raising USD 20 billion because its AI buildout, with about USD 70 billion of planned capital spending, needs cash ahead of the revenue in its USD 664 billion backlog, and it chose a blend of shares and debt to do so. The cost shows up in an offer price about 2.7% under the prior close and coupons as high as 8.650%. The risks are dilution, higher interest expense and execution. Watch the November 4 closing and the next capital spending guidance.